New Medication Shrinks Cancer in 80% of Patients - SciTechDaily

After using zanubrutinib, 80% of patients with a specific type of lymphoma had their tumors shrink in a clinical trial Lymphoma cancer is one of the most common cancers in the US, accounting for around 4% of all cancer cases. Lymphoma cancer may occur at any …

According to a recent study from the University of Michigan, the oral drug zanubrutinib was found to help most patients who had a slow-growing type of cancer known as marginal zone lymphoma. After u… [+3649 chars]

full article...